Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
HAE Transcript
Haemonetics Corporation (HAE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Neutral1-13
Badger Infrastructure Solutions Ltd. (BDGI:CA) Q3 2025 Earnings Call Transcript
Positive11-7
The earnings call presents a positive outlook with strong financial performance, including record revenue and growth in EBITDA. The Q&A section reveals minimal impact from tariffs and optimism about infrastructure projects. Despite refurbishment delays, the company's financial health is solid, with a stable debt ratio and increased EPS. The reaffirmation of guidance and shareholder return plans, along with organic growth expectations, further supports a positive sentiment. Considering the market cap, the stock price is likely to experience a moderate positive movement in the short term.
Haemonetics Corporation (HAE) Q2 2026 Earnings Call Transcript
Positive11-7
The company's financial performance shows strong operating cash flow and free cash flow, with significant year-over-year growth. Despite some guidance reaffirmations indicating declines, organic growth in key segments like plasma and hospital business is strong. The Q&A highlights positive sentiment about sustainable growth in Blood Management Technologies and plasma collections, alongside strategic initiatives like share repurchases and the Vivasure acquisition. While some uncertainties remain, overall financial health and strategic direction are positive, suggesting a stock price increase in the coming weeks.
Haemonetics Corporation (HAE) Q1 2026 Earnings Call Transcript
Positive8-9
The earnings call highlights strong organic growth, optimistic guidance, and strategic initiatives to address market challenges. Despite temporary softness in certain segments, the company is taking proactive measures, such as hiring new leaders and reorganizing teams, which instill confidence. Strong gross margins and a positive outlook for plasma and hospital segments further support a positive sentiment. However, the lack of clear guidance on plasma collections and competitive pressures in vascular closure warrant cautious optimism. Considering the market cap, a positive stock price movement of 2% to 8% is anticipated.
HAE Slides
HAE Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
